Health News
New Pulmonary Embolism Risks - Why?
Blood clots affect many parts of your body, including your lungs. A new study shows that autoimmune disorders increase the risk of blood clots, which in turn, increases the risk of a pulmonary embolism.
Which is Better for Chronic Myeloid Leukemia?
Chronic Myeloid Leukemia ( CML ) has some amazing treatment options for patients. The disease has proven to respond well to three drugs known as tyrosine kinase inhibitors. An ongoing trial is looking to see which of two of these drugs is most effective.
Improving Chronic Myeloid Leukemia Treatment
Since its introduction some years ago, Gleevec ( imatinib ) has been the drug of choice for treating patients newly diagnosed with chronic myeloid leukemia ( CML ).
Silent Stroke Causes Found Among Sickle Cell Kids
Silent stroke may be the most common form of brain injury in children with sickle cell anemia, a rare, painful blood disorder. Recently, researchers have been able to pinpoint the risk factors for such strokes in children.
Stem Cells Age Too
Everything ages over time. And human stem cells are no exception. Understanding this aging process may help explain why the elderly are more susceptible to infections and certain cancers.
Expanding Chronic Myeloid Leukemia Options
Research into more effective treatments for chronic myeloid leukemia is opening up all sorts of possibilities. Drugs are being combined, new drugs are being developed and there is even work involving a possible vaccine.
Chronic Myeloid Leukemia Advancements
The outlook for people with chronic myeloid leukemia has improved by leaps and bounds in recent years. A number of medications are now keeping the disease under wraps.
Erwinaze Approved to Treat Leukemia
The U.S. Food and Drug Administration has approved Erwinaze ( asparaginase Erwinia chrysanthemi ) to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegapargase chemotherapy drugs used to treat ALL.
Does Your Blood Type Indicate Stroke Risk?
Some individuals may be at a higher risk of stroke simply by nature of their blood type. Those with blood type AB may be at an increased risk of stroke regardless of other factors.
FDA Approves First Drug to Treat a Rare Bone Marrow Disease
The U.S. Food and Drug Administration today approved Jakafi ( ruxolitinib ), the first drug approved to specifically treat patients with the bone marrow disease myelofibrosis .